Legal News

CMA consults on Vifor Pharma's £23m commitments in iron treatment probe

Published on: 11 December 2024
Published by LNB News

LNB News 11/12/2024

Document Information

Issue Date: 11 December 2024

Published Date: 11 December 2024

Jurisdiction(s): England, Northern Ireland, Scotland and Wales

Article summary

The CMA has launched a consultation on commitments to address concerns that Vifor Pharma (Vifor) abused its dominant position by making misleading claims about a competitor’s intravenous iron treatment. The CMA has published a Notice of Intention to Accept Commitments offered by Vifor and invited representations from interested third parties on the proposed commitments. The consultation ends on 17 January 2025.

Popular documents